Internet-based transdiagnostic treatment for emotional disorders in Arabic- and Farsi-speaking refugees: a randomized controlled trial.

Internet-based transdiagnostic treatment for emotional disorders in Arabic- and Farsi-speaking refugees: a randomized controlled trial. - ALMAMAR

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024154

Enrollment

131

Registered

2021-02-01

Start date

2023-12-10

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F39 F41.1 F41.0 F40.0 F40.1 F43 F10 F19 F63

Interventions

Group 1: Internet-based intervention: 6-16 weeks of online treatment including psychoeducation and exercises. Personalized module assignment based on diagnostic information. Weekly feedback from a nat

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Legal age - Primary diagnosis of a depressive disorder, a post-traumatic stress disorder (PTSD) or an anxiety disorder (generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder) according to DSM-5 - Arabic language skills (spoken and written) - Access to the Internet (smart phone or computer) - Approval of the declaration of consent

Exclusion criteria

Exclusion criteria: - Current psychotic or bipolar disorder - Severe substance use disorder (AUDIT Score> 15 for men,> 13 for women; DUDIT Score> 25) -Acute suicidality (lack of or unclear distancing; no ability to agree/respond) - Suicide attempt in the past 12 months - Ongoing psychotherapy or unstable medication with psychotropic drugs three months before the start of the study

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the change in psychological distress as assessed using the total score of the HSCL-25 self-report version (from pre- to post-assessment).	—

Secondary

Measure	Time frame
As secondary results depression is assessed using the subscale HSCL-25 depression, anxiety using the subscale HSCL-25 anxiety and post-traumatic symptoms using the PCL-5. A suicide screening will be conducted during the diagnostic phone interview. The AUDIT will be used to assess alcohol consumption, the DUDIT to assess drug consumption, and the EQ-5D-5L to record the quality of life and, at the same time, the somatic symptom burden. Satisfaction with treatment will be assessed with the CSQ-I. Potential side effects will be measured with the NEQ.	—

Measure

Time frame

As secondary results depression is assessed using the subscale HSCL-25 depression, anxiety using the subscale HSCL-25 anxiety and post-traumatic symptoms using the PCL-5. A suicide screening will be conducted during the diagnostic phone interview. The AUDIT will be used to assess alcohol consumption, the DUDIT to assess drug consumption, and the EQ-5D-5L to record the quality of life and, at the same time, the somatic symptom burden. Satisfaction with treatment will be assessed with the CSQ-I. Potential side effects will be measured with the NEQ.

—

Countries

Germany

Contacts

Public ContactHannah Nilles

Medical School Berlin

ALMAMAR@ewi-psy.fu-berlin.de+49 30 83862672

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 27, 2026